Thailand News

Breaking news headlines

WHO approves Thailand’s anti-HIV Efavirenz

1 min read
The U.S. Army personnel in conjunction with the Thai Ministry of Public Health, the National Institute of Allergy and infectious Disease, the National Institutes of Health, Sanofi Pasteur and Global Solutions for Infectious Diseases have uncovered successful results for an AIDS vaccination

The U.S. Army personnel in conjunction with the Thai Ministry of Public Health, the National Institute of Allergy and infectious Disease, the National Institutes of Health, Sanofi Pasteur and Global Solutions for Infectious Diseases have uncovered successful results for an AIDS vaccination. Photo: USAMC-AFRIMS / United States Army.


The World Health Organization (WHO) has certified Thailand’s anti-HIV drug Efavirenz developed by the Government Pharmaceutical Organization.

GPO chairman Dr Sophon Mekthon told a press conference on Friday that Efavirenz tablet (600 grammes) was Thailand’s first anti-HIV drug and the only medication from Asean which has passed WHO prequalification programme and incorporated into WHO prequalified list.

Full story: thaipbsworld.com

By Thai PBS World


Leave a Reply

By using the site you agree and accept the terms of this Privacy and Cookies Policy. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close